COVID-19 Resource Page 



CPS is working hard, as we all are, to try to keep up with COVID19 information. Here we have provided some basic links which can take you to more in-depth information at those sites. We also attempt to post information important to pharmacy practice in context of COVID-19 in Colorado. It is in no way a comprehensive list of information, and please know that we cannot confirm it will always be the latest as things change minute to minute.  

 

If you have suggestions or items you think should be here, please contact us at [email protected]!

 


COVID-19: Implications for Pharmacists Webinar Series


In partnership with the Colorado Pharmacists Society, the CU Skaggs School of Pharmacy and Pharmaceutical Sciences is offering a free webinar series for pharmacists on the topic of COVID-19. 

We've compiled a page of the webinar recordings, presentation slides, and CE information below. 

 

Go to Webinar Series 

Community Forum/Blog 

CPS has an open forum for COVID-19 issues/concerns/questions! We add breaking information here as it comes, but any CPS members are welcome to contribute!

To navigate to the Community Forum:
Log in under your membership information →  Member Center→ Community Forum → From the Board Updates “COVID-19 Open Forum for All”
 

 


Relief Help

If you are a pharmacist, technician or intern willing to add your name to a registry of willing professionals to pitch in and work, please complete the form below:

Pharmacist Relief Volunteer Form

 

Note for Professionals Seeking Opportunities to Volunteer or Re-Enter Workforce:

Governor Polis has just announced HelpColoradoNow.org as a website for those Coloradans hoping to volunteer or assist in the COVID-19 response in a variety of ways. 

When considering whether you want to volunteer or re-enter the healthcare field, or the nature of your service, please be aware of CDC guidelines around high risk populations and exposure to the virus.

 


CO State Information

CDPHE

HCPF COVID-19 Information for Health First Colorado and CHP+ Providers and Case Managers
           - Health First Colorado Pharmacy Changes Related to COVID-19      

 


State Regulatory and Advocacy Issues

Colorado Pharmacists Society – Advocacy and Regulatory Actions

Letter to Governor Polis (3.13.20)

Email to Governor Polis’ Office (3.20.20)

Letter to US Congress (3.22.20)

Letter to HCPF regarding 1135 wavier (3.25.20)

Letter to Governor Polis (3.26.20)

NCPA pausing DIR fees on pharmacies – Letter to Congress (CPS Supported)

 

Department of Regulatory Agencies (DORA) / State Board of Pharmacy

DORA COVID-19 Updates for Licensees and Consumers

CO State Boards Draft Guidance for COVID-19 Prescribing (3.26.20)

FAQ for Healthcare Professionals Now Available (3.24.20)

Personal Protective Equipment Needed for COVID-19 Response (3.23.20)

COVID-19 Guidance for Pharmacists (3.18.20)

DORA Response to Governor's Directive - Notice to Healthcare Providers (3.18.2020)

DORA Notice Regarding Coronavirus Response (3.13.20)

Guidance for Healthcare Professionals Not Currently Licensed in Colorado (3.13.20)

Pharmacists Guide for Re-entering Workforce

Division of Professions and Occupations Emergency Licensing Measures for Healthcare Professionals


 

National Information


APHA

ASHP - General Information
           - Medication Guide

Full access:  Username: [email protected]  Password: covid-19


CDC - General Information
         - 
CDC Considerations for Pharmacies during the COVID-19 Pandemic (April 7, 2020)
         - Updated Guidance on Providing Adult and Vaccinations during COVID-19 (April 6, 2020)

CMS - Partner Toolkit

DEA - Early Refills and Controlled Substances

FDA - FDA Authorized COVID19 Tests
        - Laboratories and Manufacturers Offering Tests for COVID-19

        - FDA Emergency Use Authorization (EUA) of Hydroxychloroquine Sulfate Supplied from the Strategic National Stockpile for Treatment of COVID-19 in Certain Hospitalized Patients

       - CDER - Compounding Policy Clarifications (April 7, 2020)

NACDS - General Information

NCPA - General Information
           - General Approach


OSHA


USP
  - 
USP’s Response to the COVID-19 Pandemic

WHO - General Information
          - Coronavirus Disease (COVID-19) Outbreak: Rights, Roles and Responsibilities of Health Workers, including Key Considerations for Occupational Safety and Health  


National Regulatory and Advocacy Issues

Pharmacy Organization’s Joint Policy Recommendations to Combat the COVID-19 Pandemic

Joint Position Statement AMA / APhA / ASHP  on Inappropriate Ordering, Prescribing, or Dispensing of Medications to Treat COVID19

HHS to Governors Letter  (3.24.20)

APhA Statement

CMS:
         - Emergency Declaration Fact Sheet (3.12.20)
         - Telehealth

Minimizing Face-to-Face Contact for Medication Delivery or Dispensing

 


PBM Information

PBMs Are Taking Action to Promote Patient Access to Prescription Drugs During the COVID-19 Pandemic (April 6, 2020) 

CVS Caremark

Express Scripts Audits

Express Scripts Signatures

OptumRx

PPE  USP Letter to Relax Garbing and PPE  
         - CDC Healthcare Supply of PPE
         - CDC Strategies to Optimize the Supply of PPE and Equipment

 


Hand Sanitizer 

FDA - Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) Guidance for Industry
        - Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)
        - Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency

USP - Compounding Alcohol-Based Hand Sanitizer During COVID-19 Pandemic  (3.25.20)

WHO - Recommended Handrub Formulations

FDA Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency

 

NASPA - Letter for Regulatory Action 
             - Update on States Regulatory Action

NACDS - Letter to Congress
              - Expanding Access to Patient Care and Ensuring Pharmacy Continuity of Operations during COVID-19

NCPA - Community Pharmacists’ Recommendations to the President’s Coronavirus Task Force


Pharmacist Well-being


Headspace (Free subscription through 2020)

ASHP Well-Being Resources 

APhA Well-Being Resources and Index
 


Study/Treatment for Exposed Pharmacists or Household Contacts 


There is a COVID-19 post-exposure prophylaxis study out of the University of Minnesota that is open to all healthcare providers nationwide. 
 
They are seeking research volunteers who have been:
 
1. Closely exposed to a person with confirmed COVID-19 disease within <= 3 days;        

    AND 

2. Are a household contact or a healthcare worker;

    AND

3. Do not have current symptoms of COVID-19 disease
 
To enroll, email [email protected] They will send you an with a link to a screening survey. Prophylaxis regimen will be overnighted to you. The regimen is hydroxychloroquine 800 mg orally once, followed in 6 to 8 hours by 600 mg, then 600 mg once a day for 4 days (5 days total). On day 5 and 14 you will complete an online survey.   

You can contact David Boulware, MD (Twitter @boulware_dr) or Melanie Nicol, PharmD (Twitter @MelanieRNicol) for more information.